IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease (Q38115691)

29 August 2017

title

IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease (English)

1 reference

29 August 2017

1 reference

Jing Xue

1

1 reference

29 August 2017

Li-Ping Zhu

series ordinal

2

1 reference

29 August 2017

Qiang Wei

series ordinal

3

1 reference

29 August 2017

publication date

20 June 2013

1 reference

29 August 2017

published in

Glycoconjugate Journal

1 reference

29 August 2017

volume

30

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

735-745

1 reference

https://scigraph.springernature.com/pub.10.1007/s10719-013-9481-y

29 August 2017

exact match

0 references

cites work

The effect of individual N-glycans on enzyme activity.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Glycosylation in cellular mechanisms of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Adaptive regulation at the cell surface by N-glycosylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

The impact of glycosylation on the biological function and structure of human immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

IgA: an immune glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Structural analyses of O-glycan sugar chains on IgA1 hinge region using SELDI-TOFMS with various lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Cloning and expression of human core 1 beta1,3-galactosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Naturally occurring glycan forms of human immunoglobulins G1 and G2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

The alpha1-6-fucosyltransferase gene and its biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

N-glycosylation influences epitope expression and receptor binding structures in human IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Heterogeneity of IgG glycosylation in adult periodontal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Changes in normal glycosylation mechanisms in autoimmune rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Kidney transplantation in patients with IgA mesangial glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Interleukin 6 is an autocrine growth factor for mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Role of transforming growth factor-beta in tissue injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Tonsillectomy and IgA nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Deglycosylation of FcalphaR at N58 increases its binding to IgA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Genome-Wide Linkage Scan of a Large Family with IgA Nephropathy Localizes a Novel Susceptibility Locus to Chromosome 2q36

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-013-9481-Y

Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum

21 January 2018

1 reference

12 December 2020

Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region

1 reference

12 December 2020

Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity

1 reference

12 December 2020

Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy

1 reference

12 December 2020

Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy

1 reference

12 December 2020

Familial IgA nephropathy in southeastern Kentucky

1 reference

12 December 2020

The genetics of IgA nephropathy.

1 reference

12 December 2020

Progesterone induces a switch in oligosaccharyltransferase isoform expression: consequences on IgG N-glycosylation

1 reference

12 December 2020

Isolation and characterization of IgG1 with asymmetrical Fc glycosylation

1 reference

12 December 2020

IgA nephropathy--the case for a genetic basis becomes stronger

1 reference

12 December 2020

Mammalian glycosylation in immunity

1 reference

12 December 2020

Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy

1 reference

12 December 2020

Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy

1 reference

12 December 2020

C1 binding by mouse IgM. The effect of abnormal glycosylation at position 402 resulting from a serine to asparagine exchange at residue 406 of the mu-chain

1 reference

12 December 2020

Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes

1 reference

12 December 2020

Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys

1 reference

12 December 2020

Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA

1 reference

12 December 2020

IgG Glycosylation Changes and MBL2 Polymorphisms: Associations with Markers of Systemic Inflammation and Joint Destruction in Rheumatoid Arthritis

1 reference

12 December 2020

Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins

1 reference

12 December 2020

Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy

1 reference

12 December 2020

IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1

1 reference

12 December 2020

Localization of transforming growth factors beta1 and beta2 and epidermal growth factor in IgA nephropathy

1 reference

12 December 2020

Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels

1 reference

12 December 2020

Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study

1 reference

12 December 2020

Aberrant glycosylation of Igg heavy chain in multiple myeloma

1 reference

12 December 2020

IgA glycosylation abnormalities in the serum of patients with primary Sjögren's syndrome

1 reference

12 December 2020

Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells

1 reference

12 December 2020

1 reference

12 December 2020

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

1 reference

12 December 2020

Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis

1 reference

12 December 2020

Structural and numerical variations of the carbohydrate moiety of immunoglobulin G

1 reference

12 December 2020

IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells

1 reference

12 December 2020

PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis

1 reference

12 December 2020

Familial IgA nephropathy. Evidence of an inherited mechanism of disease

1 reference

12 December 2020

IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab

1 reference

12 December 2020

Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease

1 reference

12 December 2020

10.1007/S10719-013-9481-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1053550106

0 references

1 reference